We’re efficient, effective, and experienced—not just in one aspect of clinical trials, but in all of them.
Every aspect of a clinical study is important – from the beginning to the end, and everywhere in between. Our Site Commercial Solutions are comprehensive, end-to-end commercial management solutions built directly into your trial.
Success is always in the details, and managing the details to ensure trial and commercial success is exactly what we do. From contract negotiations to site financial management, every single aspect of a trial receives our personal attention and our care.
We are clinical researchers. We know clinical research.
Personal Concierge at your service.
Our expert Global Grants concierge service, years of experience, and single proprietary platform technology offer customized, end-to-end commercial management solutions that provide increased financial control while minimizing risk.
Our global studies are locally managed. For every study, we assign a personal clinical trial professional who will provide you with support and expertise throughout the entire process.
Building and fostering trusted relationships.
Experience personal, one-on-one relationships with highly-skilled experts with a thorough understanding of your study. This specially assigned Global Grants concierge serves as your personal go-to resource to provide support and ensure you receive seamless, efficient, high-quality, and reliable services every step of the way.
Anytime access at your fingertips.
Our proprietary single platform single process technology provides secure access to your study on-demand – wherever you are, whenever you need it.
Find everything you’re looking for with our controlled technology platform.
Receive full, on-demand transparency into every aspect of a trial, including the progress of negotiations, budget analysis, negotiations, and payments – pending, paid, and historical data.
This innovative technology goes hand-in-hand with our personalized concierge service and is just one of the valuable tools in our toolbox.
Sharing our experience.
We’ve earned the expertise we bring to the table and we’re proud to share this unparalleled expertise, insights, and experience with you.
Our Global Grants concierge service includes five service desks across the globe, legal entities in more than 80 countries, and a diverse, full-service team – fluent in 30 different languages – with a wide range of unique expertise and experience that includes budgets, contracts, and payments associated with clinical trials.
We have carried out more than $1B in contract payments and 115,000 negotiated clinical trial agreements over the past five years. No matter how many transactions we complete in the more than 80 countries in which we have legal entities, each transaction receives our undivided, personal attention.
We know what to expect – and so will you.
The trusted relationships we have established and maintain have provided us the opportunity to acquire the knowledge and a keen insight into every aspect of what’s taking place throughout a clinical trial. We know exactly what’s happening at every stage, and can help deliver results and achieve desired outcomes in the most efficient and cost-effective way possible.
A commitment to financial stewardship.
We take our responsibility to serve as financial stewards of our sponsors’ funds very seriously. We negotiate on their behalf, knowing that contracts are on the critical path to start-up, while maintaining a commitment to financial and compliance stewardship throughout each step of a clinical trial.
PRA Exceeds Tough Enrollment Goals
A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in…
Overcoming Recruitment Challenges to Meet Vaccine Study Enrollment
Through an enhanced enrollment plan, PRA helped a client meet challenging enrollment goals in a vaccine study. Our innovative strategies contributed…
Persistence Leads To High Enrollment
A Phase IV, randomized, single-blind, placebo-controlled, multi-center study to evaluate the immunogenicity of pneumococcal and influenza vaccines in…